A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

Thorvardur R. Halfdanarson, Nathan R. Foster, George P. Kim, Jeffrey P. Meyers, Thomas C. Smyrk, Ann E. McCullough, Matthew M. Ames, Jeffrry P. Jaffe, Steven R. Alberts

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)'. Together they form a unique fingerprint.

Medicine & Life Sciences